about
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Read More
4.64
0.44
(10.48%)
71,000.7
XNAS Volume
High volume+gain today
XNAS 16 Mar, 2026 3:14 PM (EDT)
Board Meeting
The next board meeting for Exicure Inc is on 18 Mar 2026 for the purpose of Exicure Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Exicure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..